Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran

Reza AFSHARI, (Addiction Research Center, Department of Clinical Toxicology, Mashhad University of Medical Sciences, Mashhad, Iran)
Hosein NOMANI, (Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran)
Fatemeh ZANIANI RIYAHI, (Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran)
Maryam Sadat NABAVINIA, (Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran)
Zohreh MIRBAGHERI, (Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran)
Mojtaba MESHKAT, (Islamic Azad University, Mashhad Branch, Mashhad, Iran)
Sina GERAYLI, (Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran)
Sina ROSTAMI, (Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran)
Zahra MESHKAT (Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran)
Turkish Journal of Medical Sciences
0 0
Yıl: 2014 Cilt: 44 Sayı: 4 Sayfa Aralığı: 656 - 660 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran

Öz:
Background/aim: Several types of the hepatitis C virus (HCV), with variations in different parts of the genome, have been isolated from different regions of the world. Based on heterogenic sequences in the isolated genome, HCV is classified into different genotypes and subtypes. Data on distribution of HCV genotypes in a certain region could be important to patient management. Therefore, this study was conducted to determine the distribution of HCV in Mashhad, Northeast Iran. Materials and methods: This cross-sectional study was conducted on 103 patients with HCV infections in Mashhad. Among the participants, at least 22 (21.4%) were intravenous drug users. HCV seropositivity was determined by an enzyme-linked immunosorbent assay and was confirmed by reverse transcriptase polymerase chain reaction. HCV-positive samples were selected for HCV genotyping using genotype specific primers. Results: Of 103 subjects, 43 (41.7%) and 34 (33.0%) had genotypes 1a and 3a, respectively. Other genotypes including 1b, 2a, 2b, 3b, and 5a were found in 4 (3.9%), 1 (1.0%), 3 (2.9%), 4 (3.9%), and 1 (1.0%), respectively. Coinfections with 2 genotypes were also observed in 11 (10.7%) patients. Genotyping for 2 (1.9%) of 103 samples did not produce any results. Conclusion: Genotypes 1a and 3a were found to be the most prevalent HCV genotypes in Mashhad, Iran.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, Guantaka RV. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 2006; 6: 198–204.
  • 2. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iranian Med 2005; 8: 84–90.
  • 3. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 3–14.
  • 4. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–832.
  • 5. Forns X, Maluenda MD, López-Labrador FX, Ampurdanes S, Olmedo E, Costa J, Simmonds JM, Sanchez-Tapias, De Anta MJ, Rodés J. Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 1996; 34: 2516–2521.
  • 6. Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, Lettieri G, Pierri P, Chionne P, Ciccaglione AR et al. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol 1998; 28: 939–944.
  • 7. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13: 223–235.
  • 8. Zein NN, Germer JJ, Wendt NK, Schimek CM, Thorvilson JN, Mitchell PS, Persing DH. Indeterminate results of the secondgeneration hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J Clin Microbiol. 1997; 35: 311–312.
  • 9. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485–1492.
  • 10. Nguyen MH, Keeffe E. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Rev Gastroenterol Disord 2004; 4: 14–21.
  • 11. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125: 634–639.
  • 12. Pozzato G, Moretti M, Crocé LS, Sasso F, Tiribelli C, Crovatto M, Santini G, Kaneko S, Unoura M, Kobayashi K. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains. J Med Virol 1995; 45: 445–450.
  • 13. Balai-Mood M. Pattern of acute poisonings in Mashhad, Iran 1993-2000. J Toxicol Clin Toxicol 2004; 42: 965–975.
  • 14. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, Rostami S, Meshkat Z. The prevalence of hepatitis C virus in Mashhad, Iran: a population-based study. Hepat Mon 2012; 13: e7723.
  • 15. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 41–63.
  • 16. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau J. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 201–207.
  • 17. Driesel G, Wirth D, Stark K, Baumgarten R, Sucker U, Schreier E. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol 1994; 139: 379–388.
  • 18. Gasich E, Eremin V, Sasinovich S, Tulinova M. HBV and HCV genotypes distribution on the territory of Belarus. Retrovirology 2012; 9: P57.
  • 19. Bouchardeau F, Chauveau P, Courouce AM, Poignet JL. Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients. Nephrol Dial Transplant 1995; 10: 2250–2252.
  • 20. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001; 20: 41–47.
  • 21. Bortolotti F, Resti M, Marcellini M, Giacchino R, Verucchi G, Nebbia G, Zancan L, Marazzi M, Barbera C, Maccabruni A et al. Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut 2005; 54: 852–857.
  • 22. Vieira DS, Alvarado-Mora MV, Botelho L, Carrilho FJ, Pinho JRR, Salcedo JM. Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil. Virol J 2011; 8: 165.
  • 23. Gonzaga RMS, Rodart IF, Reis MG, Ramalho Neto CE, Silva DW. Distribution of hepatitis C virus (HCV) genotypes in seropositive patients in the state of Alagoas, Brazil. Braz J Microbiol 2008; 39: 644–647.
  • 24. Young AM, Crosby RA, Oser CB, Leukefeld CG, Stephens DB, Havens JR. Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol 2012; 84: 1376–1387.
  • 25. Clement CG, Yang Z, Mayn JC, Dong J. HCV genotype and subtype distribution of patient samples tested at University of Texas Medical Branch in Galveston, Texas. Journal of Molecular Genetics 2010; 2: 36–40.
  • 26. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 2006; 10: 272–277.
  • 27. Amini S, Abadi MMFM, Alavian SM, Joulaie M, Ahmadipour MH. Distribution of Hepatitis C virus genotypes in Iran: a population-based study. Hepat Mon 2009; 9: 95–102.
  • 28. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006; 5: 4.
  • 29. Keyvani H, Alizadeh AHM, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res 2007; 37: 101–103.
  • 30. Hosseini‐Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran—a multicenter study. J Med Virol 2006; 78: 569–573.
  • 31. Zali MR, Mayumi M, Raoufi M, Nowroozi A. Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study. EMHJ 2000; 6: 372–377.
  • 32. Zarkesh-Esfahani SH, Kardi MT, Edalati M. Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study. Virol J 2010; 7: 69.
  • 33. Davarpanah MA, Saberi-Firouzi M, Bagheri Lankarani K, Mehrabani D, Behzad Behbahani A, Serati A, Ardebili M, Yousefi M, Khademolhosseini F, Keyvani-Amineh H. Hepatitis C virus genotype distribution in Shiraz, southern Iran. Hepat Mon 2009; 9: 122–127.
  • 34. Moradi A, Semnani S, Keshtkar A, Khodabakhshi B, Kazeminejad V, Molana A, Roshandel G, Besharat S. Distribution of hepatitis C virus genotype among HCV infected patients in Golestan Province, Iran. Govaresh 2011; 15: 7–13.
  • 35. Tajbakhsh E, Dosti A, Tajbakhsh S, Momeni M, Tajbakhsh F. Determination of hepatitis C virus genotypes among HCV positive patients in Shahrekord, Iran. AJMR 2011; 5: 5910– 5915.
  • 36. Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, North of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon 2011; 11: 178–181.
  • 37. Bozdayı A, Aslan N, Bozdayı G, Türkyılmaz A, Sengezer T, Wend U, Erkan Ö, Aydemir F, Zakirhodjaev S, Orucov Ş et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 2004; 149: 2115–2129.
  • 38. Hejazi MS, Ghotaslou R, Hagh MF, Sadigh YM. Genotyping of hepatitis C virus in northwest of Iran. Biotechnology 2007; 6: 302–308.
  • 39. Ali S, Ali I, Azam S, Ahmad B. Frequency distribution of HCV genotypes among chronic hepatitis C patients of Khyber Pakhtunkhwa. Virol J 2011; 8: 193.
  • 40. Bashir MF, Haider MS, Rashid N, Riaz S. Distribution of hepatitis C virus (HCV) genotypes in different remote cities of Pakistan. AJMR 2012; 6: 4747–4751.
  • 41. Lee DS, Sung YC, Whang YS. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996; 49: 55–60.
  • 42. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, PytelKrolczuk B, Prokopowicz D, Chyczewski L. Changing HCV genotypes distribution in Poland—relation to source and time of infection. J Clin Virol 2008; 42: 156–159.
  • 43. Oliveira M, Bastos F, Sabino R, Paetzold U, Schreier E, Pauli G, Yoshida C. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res 1999; 32: 279–282.
  • 44. Samimi-Rad K, Toosi MN, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AM, Hassanpour G, Alavian SM, Asgari F. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol 2012; 157: 1959–1965.
  • 45. Svirtlih N, Delic D, Simonovic J, Jevtovic D, Dokic L, Gvozdenovic E, Boricic I, Terzic D, Pavic S, Neskovic G et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol 2007; 13: 355–360.
  • 46. López-Labrador FX, Ampurdanés S, Forns X, Castells A, Sáiz JC, Costa J, Bruix J, Sánchez Tapias JM, Jiménez de Anta MT, Rodés J. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27: 959–965.
  • 47. Vossughinia H, Goshayeshi LA, Rafatpanah Bayegi H, Sima H, Kazemi A, Erfan S, Abedini S, Goshayeshi L, Ghaffarzadegan K, Nomani H et al. Prevalence of hepatitis C virus genotypes in Mashhad, Northeast Iran. Iran J Public Health 2012; 41: 56–61.
APA AFSHARI R, NOMANI H, ZANIANI RIYAHI F, NABAVINIA M, MIRBAGHERI Z, MESHKAT M, GERAYLI S, ROSTAMI S, MESHKAT Z (2014). Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. , 656 - 660.
Chicago AFSHARI Reza,NOMANI Hosein,ZANIANI RIYAHI Fatemeh,NABAVINIA Maryam Sadat,MIRBAGHERI Zohreh,MESHKAT Mojtaba,GERAYLI Sina,ROSTAMI Sina,MESHKAT Zahra Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. (2014): 656 - 660.
MLA AFSHARI Reza,NOMANI Hosein,ZANIANI RIYAHI Fatemeh,NABAVINIA Maryam Sadat,MIRBAGHERI Zohreh,MESHKAT Mojtaba,GERAYLI Sina,ROSTAMI Sina,MESHKAT Zahra Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. , 2014, ss.656 - 660.
AMA AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. . 2014; 656 - 660.
Vancouver AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. . 2014; 656 - 660.
IEEE AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z "Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran." , ss.656 - 660, 2014.
ISNAD AFSHARI, Reza vd. "Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran". (2014), 656-660.
APA AFSHARI R, NOMANI H, ZANIANI RIYAHI F, NABAVINIA M, MIRBAGHERI Z, MESHKAT M, GERAYLI S, ROSTAMI S, MESHKAT Z (2014). Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turkish Journal of Medical Sciences, 44(4), 656 - 660.
Chicago AFSHARI Reza,NOMANI Hosein,ZANIANI RIYAHI Fatemeh,NABAVINIA Maryam Sadat,MIRBAGHERI Zohreh,MESHKAT Mojtaba,GERAYLI Sina,ROSTAMI Sina,MESHKAT Zahra Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turkish Journal of Medical Sciences 44, no.4 (2014): 656 - 660.
MLA AFSHARI Reza,NOMANI Hosein,ZANIANI RIYAHI Fatemeh,NABAVINIA Maryam Sadat,MIRBAGHERI Zohreh,MESHKAT Mojtaba,GERAYLI Sina,ROSTAMI Sina,MESHKAT Zahra Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turkish Journal of Medical Sciences, vol.44, no.4, 2014, ss.656 - 660.
AMA AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turkish Journal of Medical Sciences. 2014; 44(4): 656 - 660.
Vancouver AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran. Turkish Journal of Medical Sciences. 2014; 44(4): 656 - 660.
IEEE AFSHARI R,NOMANI H,ZANIANI RIYAHI F,NABAVINIA M,MIRBAGHERI Z,MESHKAT M,GERAYLI S,ROSTAMI S,MESHKAT Z "Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran." Turkish Journal of Medical Sciences, 44, ss.656 - 660, 2014.
ISNAD AFSHARI, Reza vd. "Genotype distribution of hepatitis C virus in Khorasan Razavi Province, Iran". Turkish Journal of Medical Sciences 44/4 (2014), 656-660.
Sayfa Oluşturulma Tarihi
23-04-2024 0:33

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları